Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02051517 · ClinicalTrials.gov registry record

Vitreous Chemistry Analysis

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
3
Enrollment target

NCT02051517: Completed study, sponsored by University of Minnesota.

NCT02051517 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02051517 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
3 participants
Enrollment target

Study Summary

The aim of this study is to expand the understanding of the vitreous, its solute chemistry, and the normal relationship of that chemistry to the chemistry of the systemic circulation in humans. Sample human vitreous from patients undergoing vitrectomy surgery and compare to results of metabolic chemistry panel from subject. Allow the research team to extract .2ml sample of the .5ml - 1.0ml vitreous that is normally extracted during a routine undiluted vitreous biopsy, a standard procedure performed for various indications. Blood draw for metabolic chemistry panel (1-2 ml).

Primary Outcome

Collection of Vitreous to gain a better understanding of its solute chemistry and the normal relationship of that chemistry to the chemistry of the systemic circulation in humans.

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2013-05
Est. Completion 2016-12
University of Minnesota

966 total trials

What the finished NCT02051517 record still lists

NCT02051517 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02051517 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02051517 about?

NCT02051517 is a clinical study titled "Vitreous Chemistry Analysis". The aim of this study is to expand the understanding of the vitreous, its solute chemistry, and the normal relationship of that chemistry to the chemistry of the systemic circulation in humans. Sample human vitreous from patients undergoing vitrectomy surgery and compare to results of metabolic che...

What is the current status of trial NCT02051517?

This trial is currently completed. The enrollment target is 3 participants. The study started on 2013-05. Estimated completion is 2016-12.

Who is sponsoring clinical trial NCT02051517?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02051517, the US trial registry maintained by the National Library of Medicine. NCT02051517 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.